NEW YORK (GenomeWeb) – Looking at the gene sequences that have gone awry in patients with myelodysplastic syndrome (MDS) can offer clues to the cases most likely to progress to bone marrow failure after allogeneic hematopoietic stem cell transplant treatment, a new study has found.